Symbol classroom

LZ

Chart the move, read why OppHub America is covering it, then watch or talk it through — not a Google Finance clone.

LZ

TradingView chart · search any symbol inside the widget · informational only

Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice

0 watching· join free Discuss in Community Join Community

Learn the move

Use this page as a short classroom: (1) scan the chart for the recent move, (2) read OppHub America Insider / Policy / company notes on LZ, (3) note what to watch next, then (4) add LZ to Watch or take the conversation to Community / Club.

Money angle — * Investors who purchased Exelixis (N: ) stock and incurred losses may be eligible for an investigation into potential securities law violations. Shareholders are advised to gather relevant brokerage records.

Latest coverage on LZ

Recent OppHub America stories tagged LZ — Insider, Policy, CEO Desk, and market catalysts

LZ policy →CEO Desk →Explore →

PolicyAugust 10, 2026

$EXEL

$UTI

$LZ

Exelixis (EXEL) Faces Investigation Over Revenue Guidance Disclosures

Exelixis (NASDAQ: EXEL) is under investigation by Levi & Korsinsky, LLP regarding potential misstatements about its 2026 revenue guidance and the ramp of its neuroendocrine-tumor business. The probe follows a significant stock decline after the company lowered its outlook on August 5, 2026, weeks after reiterating it. Investors who lost money are encouraged to submit their loss information.

pharmabiotechmanaged care

* Investors who purchased Exelixis (N: ) stock and incurred losses may be eligible for an investigation into potential securities law violations. Shareholders are advised to gather relevant brokerage records.

Read desk note →Chart $EXEL